Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MATCH: Carvedilol for Intradialytic Hypertension
NCT00827775Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jun 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of carvedilol in Intradialytic hypertension (IDH) (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Endothelial Progenitor Cells at 12 weeks. Started Jun 2009; status: completed.
02
Drugs
carvedilol
03
Conditions
Intradialytic hypertension (IDH)
Beyond the preview
Go deeper on NCT00827775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827775.